Mesalamine

Back to search

Molecule Structure

Scientific Name

Mesalamine

Description of the Drug

Mesalazine is an aminosalicylate drug used to treat mild to moderate active ulcerative colitis and also to maintain remission once achieved.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00244

Brand Name(s)

Apriso, Asacol, Asacol hd, Canasa, Coltec ec, Delzicol, Ipocol, Lialda, Mesalamine, Mesren mr, Mezavant xl, Octasa, Pentasa, Pentasa sr, Rowasa, Salofalk, Sfrowasa

Company Owner(s)

Alkem Laboratories Ltd, Takeda Pharmaceuticals Usa Inc, Actavis Mid Atlantic Llc, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Llc, Zydus Pharmaceuticals Usa Inc, Allergan Sales Llc, Meda Pharmaceuticals Inc, Actavis Laboratories Fl Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Teva Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Arachidonate 5-lipoxygenase SINGLE PROTEIN INHIBITOR CHEMBL215
Cyclooxygenase PROTEIN FAMILY INHIBITOR CHEMBL2094253
Peroxisome proliferator-activated receptor gamma SINGLE PROTEIN AGONIST CHEMBL235

Unichem Links

Atlas mesalazine
SureChEMBL SCHEMBL18038934 SCHEMBL31297
PharmGKB PA450384
Human Metabolome Database HMDB0014389
DrugBank DB00244
PubChem: Thomson Pharma 15170925
PubChem 4075
Mcule MCULE-5752745805
NMRShiftDB 20037775
LINCS LSM-5427
Nikkaji J32.511B
BindingDB 60918
EPA CompTox Dashboard DTXSID5024506
DrugCentral 1710
Brenda 36968 3607 109764 256575 1817
ChemicalBook CB1480481
Guide to Pharmacology 2700
rxnorm MESALAMINE APRISO ROWASA DELZICOL PENTASA CANASA LIALDA ASACOL
PubChem: Drugs of the Future 12015286
ChEBI 6775
ZINC ZINC000000001688